Liberty Street Advisors Increases Stake in Voyager Technologies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 24 2026
0mins
Should l Buy VOYG?
Source: Yahoo Finance
Voyager Technologies Inc's stock fell by 7.86% as it crossed below the 20-day SMA, reflecting a challenging trading environment.
On January 23, Liberty Street Advisors disclosed an increase of 136,925 shares in Voyager Technologies, with an estimated trade size of $3.71 million, indicating strong confidence in the company's future prospects. Voyager reported $39.6 million in Q3 revenue, driven by a 31% growth in its Defense and National Security segment, and guided full-year sales towards the high end of its $165 million to $170 million range, indicating robust market demand. With $413 million in cash and no debt, Voyager has the financial flexibility to fund Starlab development and pursue bolt-on acquisitions, enhancing its competitive position in the aerospace and defense sectors.
The increase in stake by Liberty Street Advisors highlights the positive sentiment surrounding Voyager Technologies, despite the recent stock decline. The company's strong revenue growth and financial health position it well for future opportunities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VOYG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VOYG
Wall Street analysts forecast VOYG stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 28.110
Low
25.00
Averages
38.80
High
45.00
Current: 28.110
Low
25.00
Averages
38.80
High
45.00
About VOYG
Voyager Technologies, Inc. is a defense technology and space solutions company. The Company is developing and delivering transformative, mission-critical solutions to customers, enabled by its advanced technology, analytics and space infrastructure capabilities. Its solutions include communications and intelligence collection systems, defense systems, advanced space technology, in-space infrastructure and space mission services. The Company’s business consists of diversified solutions across three business segments: Defense & National Security provides mission-critical solutions to protect dynamic and contested domains; Space Solutions delivers space infrastructure, advanced space technology, science systems and mission services that power commercial, academic and government missions from low-Earth orbit to deep space, and Starlab Space Stations, is a commercial space station planned to succeed the ISS and provide continued permanent human presence in space.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Starlab Partners with USLLC for Space-Based Semiconductor Production
- Partnership Agreement: Starlab Space LLC has signed a payload reservation agreement with United Semiconductors LLC to transition its space-based semiconductor crystal growth technology from the International Space Station to commercial-scale production in low Earth orbit, significantly enhancing the stability of the U.S. semiconductor supply chain.
- Microgravity Advantages: USLLC's successful ISS mission demonstrated that microgravity provides a uniquely stable environment for improving material uniformity and yield of complex semiconductor alloys, which is expected to deliver high-performance semiconductor materials for aerospace, AI, and national security applications.
- Cost Reduction: By leveraging Starlab's internal and external payload platforms, USLLC aims to expand payload throughput, shorten logistics timelines, and strengthen intellectual property protections, thereby reducing production costs associated with space-manufactured semiconductor materials and reinforcing long-term leadership in technology supply chains.
- Market-Driven Model: Starlab's market-driven business model is designed to minimize costs and risks for researchers and commercial partners, with its single-launch, no-assembly-required architecture enabling full certification and operational readiness within weeks of launch, maximizing efficiency for payload customers.
See More
Microgravity Crystal Growth Enhances Semiconductor Supply Chains
- Transformative Partnership: Starlab Space has signed a payload reservation agreement with United Semiconductors to transition space-based semiconductor crystal growth technology from demonstration aboard the ISS to commercial-scale production in low Earth orbit, thereby enhancing U.S. leadership in advanced materials manufacturing.
- Efficiency Gains: By leveraging Starlab's internal and external payload platforms, USLLC aims to expand payload throughput, shorten logistics timelines, strengthen intellectual property protections, and reduce production costs associated with space-manufactured semiconductor materials, significantly improving production efficiency.
- Microgravity Benefits: USLLC's ISS mission demonstrated microgravity's unique stability for bulk and thin-film crystal growth of complex semiconductor and semimetal alloys, enabling improved material uniformity and higher yields, which enhances device performance and holds substantial commercial value.
- Market-Driven Model: Starlab's market-driven business model is designed to reduce costs, complexity, and risks for researchers and commercial partners, with its single-launch, no-assembly-required architecture ensuring full certification and operational readiness within weeks of launch, maximizing efficiency for payload customers.
See More
LambdaVision Advances Commercialization of Artificial Retina
- Commercial Space Reservation: LambdaVision has secured a strategic partnership with Starlab Space LLC to pre-book commercial space in low-Earth orbit, paving the way for scaling the manufacturing of its protein-based artificial retina, which is expected to significantly enhance the company's competitive position in treating retinal degenerative diseases.
- Funding Support: The company recently closed a $7 million seed funding round, providing runway into 2027 and further validating its innovative space-based manufacturing technology aimed at restoring vision for patients, thereby expanding its market reach.
- Microgravity Advantages: By leveraging microgravity for production, LambdaVision's layer-by-layer manufacturing process improves the homogeneity and stability of protein films, potentially leading to breakthroughs in biosensors, optical systems, and drug delivery applications, thus enhancing the market applicability of its technology.
- Future Development Prospects: LambdaVision's artificial retina technology not only focuses on vision restoration but also lays the groundwork for future clinical research, showcasing the transformative potential of space biotechnology and likely attracting further investment and collaboration opportunities.
See More
LambdaVision Partners with Starlab for Space-Based Retina Production
- Agreement Signed: LambdaVision has entered into a reservation agreement with Starlab to extend its research and production activities for protein-based artificial retinas to a commercial space station, ensuring continued access to microgravity as the International Space Station approaches retirement.
- Enhanced Technical Advantages: The layer-by-layer assembly process of LambdaVision is significantly improved in the low Earth orbit environment, where reduced gravity enhances the homogeneity, stability, and performance of thin films, laying the groundwork for future biomedical production.
- Significant Market Potential: This agreement not only supports LambdaVision's initial application in vision restoration but also paves the way for its layer-by-layer protein manufacturing platform's broader potential in biosensors, optical systems, and drug delivery, demonstrating the feasibility of commercial-scale production in microgravity.
- Sustainable Manufacturing Transition: Starlab's market-driven business model aims to reduce costs and risks for research and commercial partners, ensuring full certification and operational readiness within weeks of launch, thereby maximizing efficiency and minimizing delays.
See More
Starlab Completes Critical Design Review for Next-Gen Space Station
- Successful Design Review: Starlab Space LLC has successfully completed its Commercial Critical Design Review (CCDR), marking a decisive transition from design to manufacturing and systems integration, ensuring continuity of human presence and research in low Earth orbit.
- Technical Maturity Confirmation: The CCDR confirms that Starlab's architecture, safety approach, and performance requirements are technically mature and executable, allowing the program to fully enter fabrication, testing, and assembly phases, thereby ensuring ongoing capabilities for science and industry.
- Business Plan Validation: Starlab's business plan and model have been reviewed, substantiating a sustainable revenue model and ISS-equivalent payload and crew capabilities, demonstrating its development as a market-driven platform rather than a government-dependent asset.
- Global Collaboration Achievement: This achievement reflects years of disciplined engineering and close coordination with NASA, ESA, and JAXA, along with strong collaboration across a global team, validating both Starlab's technical maturity and the credibility of its underlying business case.
See More
Intense Competition for International Space Station Successor
- Axiom Funding Success: Axiom Space raised $350 million last week from investors including Type One Ventures and 1789 Capital, with funds earmarked for completing the first module's construction, scheduled for launch in 2028 to dock with the ISS, thereby laying the groundwork for its future independent space station.
- Module Development Progress: The first module, a Payload Power Thermal Module (PPTM), is set to link with a second habitation module in 2029, showcasing Axiom's strategic timeline and commitment to establishing a new independent space station.
- Market Competition Landscape: With Axiom and Vast racing to develop new space stations, Axiom's module is expected to be operational in 2029, potentially ahead of Vast's Haven-1, which could give Axiom a competitive edge in the market.
- Uncertain IPO Prospects: Despite Axiom's funding achievements, its private market valuation has declined from $2.6 billion in 2023 to $2 billion in 2025, raising concerns about its long-term profitability and casting doubt on its IPO prospects.
See More
Starlab Partners with USLLC for Space-Based Semiconductor Production
- Partnership Agreement: Starlab Space LLC has signed a payload reservation agreement with United Semiconductors LLC to transition its space-based semiconductor crystal growth technology from the International Space Station to commercial-scale production in low Earth orbit, significantly enhancing the stability of the U.S. semiconductor supply chain.
- Microgravity Advantages: USLLC's successful ISS mission demonstrated that microgravity provides a uniquely stable environment for improving material uniformity and yield of complex semiconductor alloys, which is expected to deliver high-performance semiconductor materials for aerospace, AI, and national security applications.
- Cost Reduction: By leveraging Starlab's internal and external payload platforms, USLLC aims to expand payload throughput, shorten logistics timelines, and strengthen intellectual property protections, thereby reducing production costs associated with space-manufactured semiconductor materials and reinforcing long-term leadership in technology supply chains.
- Market-Driven Model: Starlab's market-driven business model is designed to minimize costs and risks for researchers and commercial partners, with its single-launch, no-assembly-required architecture enabling full certification and operational readiness within weeks of launch, maximizing efficiency for payload customers.
See More
Microgravity Crystal Growth Enhances Semiconductor Supply Chains
- Transformative Partnership: Starlab Space has signed a payload reservation agreement with United Semiconductors to transition space-based semiconductor crystal growth technology from demonstration aboard the ISS to commercial-scale production in low Earth orbit, thereby enhancing U.S. leadership in advanced materials manufacturing.
- Efficiency Gains: By leveraging Starlab's internal and external payload platforms, USLLC aims to expand payload throughput, shorten logistics timelines, strengthen intellectual property protections, and reduce production costs associated with space-manufactured semiconductor materials, significantly improving production efficiency.
- Microgravity Benefits: USLLC's ISS mission demonstrated microgravity's unique stability for bulk and thin-film crystal growth of complex semiconductor and semimetal alloys, enabling improved material uniformity and higher yields, which enhances device performance and holds substantial commercial value.
- Market-Driven Model: Starlab's market-driven business model is designed to reduce costs, complexity, and risks for researchers and commercial partners, with its single-launch, no-assembly-required architecture ensuring full certification and operational readiness within weeks of launch, maximizing efficiency for payload customers.
See More
LambdaVision Advances Commercialization of Artificial Retina
- Commercial Space Reservation: LambdaVision has secured a strategic partnership with Starlab Space LLC to pre-book commercial space in low-Earth orbit, paving the way for scaling the manufacturing of its protein-based artificial retina, which is expected to significantly enhance the company's competitive position in treating retinal degenerative diseases.
- Funding Support: The company recently closed a $7 million seed funding round, providing runway into 2027 and further validating its innovative space-based manufacturing technology aimed at restoring vision for patients, thereby expanding its market reach.
- Microgravity Advantages: By leveraging microgravity for production, LambdaVision's layer-by-layer manufacturing process improves the homogeneity and stability of protein films, potentially leading to breakthroughs in biosensors, optical systems, and drug delivery applications, thus enhancing the market applicability of its technology.
- Future Development Prospects: LambdaVision's artificial retina technology not only focuses on vision restoration but also lays the groundwork for future clinical research, showcasing the transformative potential of space biotechnology and likely attracting further investment and collaboration opportunities.
See More
LambdaVision Partners with Starlab for Space-Based Retina Production
- Agreement Signed: LambdaVision has entered into a reservation agreement with Starlab to extend its research and production activities for protein-based artificial retinas to a commercial space station, ensuring continued access to microgravity as the International Space Station approaches retirement.
- Enhanced Technical Advantages: The layer-by-layer assembly process of LambdaVision is significantly improved in the low Earth orbit environment, where reduced gravity enhances the homogeneity, stability, and performance of thin films, laying the groundwork for future biomedical production.
- Significant Market Potential: This agreement not only supports LambdaVision's initial application in vision restoration but also paves the way for its layer-by-layer protein manufacturing platform's broader potential in biosensors, optical systems, and drug delivery, demonstrating the feasibility of commercial-scale production in microgravity.
- Sustainable Manufacturing Transition: Starlab's market-driven business model aims to reduce costs and risks for research and commercial partners, ensuring full certification and operational readiness within weeks of launch, thereby maximizing efficiency and minimizing delays.
See More
Starlab Completes Critical Design Review for Next-Gen Space Station
- Successful Design Review: Starlab Space LLC has successfully completed its Commercial Critical Design Review (CCDR), marking a decisive transition from design to manufacturing and systems integration, ensuring continuity of human presence and research in low Earth orbit.
- Technical Maturity Confirmation: The CCDR confirms that Starlab's architecture, safety approach, and performance requirements are technically mature and executable, allowing the program to fully enter fabrication, testing, and assembly phases, thereby ensuring ongoing capabilities for science and industry.
- Business Plan Validation: Starlab's business plan and model have been reviewed, substantiating a sustainable revenue model and ISS-equivalent payload and crew capabilities, demonstrating its development as a market-driven platform rather than a government-dependent asset.
- Global Collaboration Achievement: This achievement reflects years of disciplined engineering and close coordination with NASA, ESA, and JAXA, along with strong collaboration across a global team, validating both Starlab's technical maturity and the credibility of its underlying business case.
See More
Intense Competition for International Space Station Successor
- Axiom Funding Success: Axiom Space raised $350 million last week from investors including Type One Ventures and 1789 Capital, with funds earmarked for completing the first module's construction, scheduled for launch in 2028 to dock with the ISS, thereby laying the groundwork for its future independent space station.
- Module Development Progress: The first module, a Payload Power Thermal Module (PPTM), is set to link with a second habitation module in 2029, showcasing Axiom's strategic timeline and commitment to establishing a new independent space station.
- Market Competition Landscape: With Axiom and Vast racing to develop new space stations, Axiom's module is expected to be operational in 2029, potentially ahead of Vast's Haven-1, which could give Axiom a competitive edge in the market.
- Uncertain IPO Prospects: Despite Axiom's funding achievements, its private market valuation has declined from $2.6 billion in 2023 to $2 billion in 2025, raising concerns about its long-term profitability and casting doubt on its IPO prospects.
See More
